Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207778 · ClinicalTrials.gov registry record
Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 77
- Enrollment target
NCT01207778 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 77 participants.
The verdict
NCT01207778 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
Approximately 60,000 premature infants are born each year who weigh less than 1,500 grams,many of whom sustain brain damage because of their prematurity. This study is designed to evaluate the long-term developmental effects of one promising neuroprotective treatment,erythropoietin (Epo), when given in the neonatal period. Using detailed neurodevelopmental testing and state-of-the-art brain imaging, we hope to determine whether this is an effective treatment to prevent brain injury associated with prematurity, and to lay the groundwork for further studies to improve the developmental outcome of infants delivered prematurely.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2010-03 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207778
The ClinicalTrials.gov registry entry for NCT01207778 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01207778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01207778 about?
NCT01207778 is a clinical study titled "Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin". Approximately 60,000 premature infants are born each year who weigh less than 1,500 grams,many of whom sustain brain damage because of their prematurity. This study is designed to evaluate the long-term developmental effects of one promising neuroprotective treatment,erythropoietin (Epo), when given...
What is the current status of trial NCT01207778?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2010-03. Estimated completion is 2020-12-31.
Who is sponsoring clinical trial NCT01207778?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.